Evaluation of antimicrobial effect of hops extracts on intramacrophages Brucella abortus and B. melitensis

Jundishapur Journal of Microbiology

Volumn 4, Issue SUPPL. 1, 2011, Pages

  Shapouri, Reza ^a   Rahnema, Mehdi ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Antibacterial activity; B. melitensis; Brucella abortus; Cell culture; Hops extract

Indexed keywords

ACETONE; ALCOHOL; HUMULUS LUPULUS EXTRACT; WATER;

AGAR DIFFUSION; ANIMAL CELL; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BROTH DILUTION; BRUCELLA ABORTUS; BRUCELLA MELITENSIS; BRUCELLOSIS; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; SENSITIVITY ANALYSIS;

ANIMALIA; BRUCELLA; BRUCELLA MELITENSIS; BRUCELLA MELITENSIS BIOVAR ABORTUS; HUMULUS; HUMULUS LUPULUS;

EID: 79958734053     PISSN: 20083645     EISSN: 20084161     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Boschirol ML, Foulongne V, O'Callaghan D. Brucellosis: a worldwide zoonosis. Curr Opin Microbiol. 2001; 4: 58-64.
2. Olivera SC, Soeurt N, Splitter G. Molecular and cellular interactions between Brucella abortus antigens and host immune responses. Vet Microbiol. 2002; 90: 417-24.
3. Moreno E, Cloeckaert A, Moriyon I. Brucella evolution and taxonomy. Vet Microbiol. 2002; 90: 209-27.
4. Gorvel JP, Edgardo M. Brucella intracellular life: invasion to intracellular replication. Vet Microbiol. 2002; 90: 281-97.
5. Jinkyung K, Splitter GA. Molecular host- pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin Microbiol Rev. 2003; 16: 65-78.
6. Rittig MG, Alvarez-Martinez MT, Porte F, Liautard JP, Rouot B. Intracellular survival of Brucella spp. in human monocytes involves conventional uptake but special phagosomes. Infect Immun. 2001; 69: 3995-4006.
7. Godfroid J, Kasbohrer A. Brucellosis in the European Union and Norway at the turn of the twenty-first century. Vet Microbiol. 2002; 90: 135-45.
8. Moreno E. Brucellosis in Central America. Vet Microbiol. 2002; 90: 31-8.
9. Refai M. Incidence and control of brucellosis in the Near East region. Vet Microbiol. 2002; 90: 81-110.
10. Ragan VE. The Animal and Plant Health Inspection Service (APHIS) brucellosis eradication program in the United States. Vet Microbiol. 2002; 90: 11-8.
11. Whatmore AM. Current understanding of the genetic diversity of Brucella, an expanding genus of zoonotic pathogens. Infect Genet Evol. 2009; 9: 1168-84.
12. Zanoli P, Zavatti M. Pharmacognostic and pharmacological profile of Humulus lupulus L. J Ethnopharmacol. 2008; 116: 383-96.
13. Kac J, Plazar J, Mlinaric A, Zegura B, Lah TT, Filipic M. Antimutagenicity of hops (Humulus lupulus L.): bioassay-directed fractionation and isolation of xanthohumol. Phytomedicine. 2008; 15: 216-20.
14. Srinivasan D, Nathan S, Suresh T, Perumalsamy PL. Antimicrobial activity of certain Indian medicinal plants used in folkloric medicine. J Ethnopharmacol. 2001; 74: 217-20.
15. Stavri M, Schneider R, O'Donnell G, Lechner D, Bucar F, Gibbons S. The antimycobacterial components of hops (Humulus lupulus) and their dereplication. Phytother Res. 2004; 18: 774-6.
16. Battacharya S, Virani S, Zavro M, Haas GJ. Inhibition of Streptococcus mutans and other oral Streptococci by hop constituents. Econ Bot. 2003; 57: 118-25.
17. Nguyen-Pouplin J, Tran H, Tran H, et al. Antimicrobial and cytotoxic activities of ethnopharmacologically selected medicinal plants from South Vietnam. J Ethnopharmacol. 2007; 109: 417-27.
18. Shapiro DS, Wong Jd. Brucella. In: Murray P, Baron E. (eds), Manual of clinical microbiology. ASM Press Pub, 1999; 625-31.
19. Maria-Pilar JB, Dudal Sh, Dornand J, Gross A. Cellular bioterrorism: how Brucella corrupts macrophage physiology to promote invasion and proliferation. Clin Immunol. 2005; 114: 227-38.
20. Turkmani A, Psaroulaki A, Christidou A, et al. Uptake of ciprofloxacin and ofloxacin by 2 Brucella strains and their fluoroquinolone-resistant variants under different conditions. Diagn Microbiol Infect Dis. 2007; 59: 447-51.
21. Iqbal A, Beg AZ. Antimicrobial and phytochemical studies on 45 Indian medicinal plants against multi-drug resistant human pathogens. J Ethnopharmacol. 2001; 74: 113-23.
22. Rios JL, Recio MC. Medicinal plants and antimicrobial activity. J Ethnopharmacol. 2005; 100: 80-4.
23. Pei J, Turse JE, Ficht TA. Evidence of Brucella abortus OPS dictating uptake and restricting NF-kB activation in murine macrophages. Microbes Infect. 2008; 10: 582-90.
24. Sun YH, den Hartigh AB, de Lima Santos R, Adams LG, Tsolis RM. VirB-mediated survival of Brucella abortus in mice and macrophages is independent of a functional inducible nitric oxid synthase or NADPH oxidase in macrophages. Infect Immun. 2002; 70: 4826-32.
25. Haas GJ, Barsumian R. Antimicrobial activity of hop resins. J Food Prot. 1994; 57: 59-61.
26. Gerhauser C. Broad spectrum anti infective potential of xanthohumol from hop (Humulus lupulus L.) in comparison with activities of other hop constituents and xanthohumol metabolites. Mol Nutr Food Res. 2005; 49: 827-31.
27. Chadwick LR, Pauli GF, Farnsworth NR. The pharmacognosy of Humulus lupulus L. (hops) with an emphasis on estrogenic properties. Phytomedicine. 2006; 13: 119-31.
28. Natarajan P, Katta S, Andrei I, Ambati VBR, Leonida M, Hass GJ. Positive antibacterial co-action between hop (Humulus lupulus) constituents and selected antibiotics. Phytomedicine. 2008; 15: 194-201.
29. Yamaguchi N, Yamaguchi KS, Ono M. In vitro evaluation of antibacterial, anticollagenase, and antioxidant activities of hop components (Humulus lupulus) addressing acne vulgaris. Phytomedicine. 2009; 16: 369-76.
30. Buckwold VE, Wilson RJ, Nalca A, et al. Antiviral activity of hop constituents against a series of DNA and RNA viruses. Antiviral Res. 2004; 61: 57-62.